Properties (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:XYZ_Biotech
|
| gptkbp:awards |
Best Workplace 2022
Innovation Award 2023 |
| gptkbp:CEO |
gptkb:John_Doe
|
| gptkbp:clinicalTrials |
Phase 3
Real-World Evidence Studies Patient-Centric Trials |
| gptkbp:communityInvolvement |
Health Awareness Campaigns
Sponsorship of Medical Conferences |
| gptkbp:culturalHeritage |
Inclusive Hiring Practices
Employee_Resource_Groups |
| gptkbp:employees |
5000
|
| gptkbp:environmentalInitiatives |
Sustainable Packaging
Carbon Neutral Goals |
| gptkbp:financialPerformance |
Stock Price Growth
Profit Margin Increase |
| gptkbp:financials |
Local Charities
Health Research Grants |
| gptkbp:founded |
2001
|
| gptkbp:futurePlans |
Expansion into New Markets
Investment in R&D |
| gptkbp:headquarters |
gptkb:New_York,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Global Pharma Inc.
|
| gptkbp:investmentFocus |
Biotechnology Startups
Digital_Health_Solutions |
| gptkbp:market |
Global
New Cancer Treatment 2022 New Diabetes Drug 2023 New Vaccine 2021 |
| gptkbp:marketShare |
10% in Europe
15% in North America 8% in Asia |
| gptkbp:partnerships |
gptkb:ABC_Research_Institute
|
| gptkbp:patentCitation |
200
|
| gptkbp:products |
Vaccines
Over-the-Counter Medications Prescription Drugs |
| gptkbp:regulatoryCompliance |
EMA_Approved
FDA_Approved |
| gptkbp:researchFocus |
Cardiology
Oncology Neurology |
| gptkbp:researchInterest |
Industry Alliances
University_Partnerships |
| gptkbp:revenue |
$1 billion
|
| gptkbp:socialMedia |
Facebook
|
| gptkbp:subsidiary |
Global Pharma Latin America
Global_Pharma_Asia Global_Pharma_Europe |
| gptkbp:supplyChain |
Cold_Chain_Logistics
Global_Distribution_Network |
| gptkbp:training |
Leadership Development Programs
Continuous_Education_Programs |
| gptkbp:website |
www.globalpharma.com
|